Impact of the COVID-19 pandemic on CVD prevention between different socioeconomic groups in Switzerland.
Fiche du document
- doi: 10.1136/openhrt-2023-002368
- issn: 2053-3624
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1136/openhrt-2023-002368
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/37730269
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/2053-3624
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_A6A8509AA4228
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
Tsʻeu Tzʻu Ci Tse Blood pressure, High Vascular hypertension High blood pressureCiter ce document
K.K. Maung et al., « Impact of the COVID-19 pandemic on CVD prevention between different socioeconomic groups in Switzerland. », Serveur académique Lausannois, ID : 10.1136/openhrt-2023-002368
Métriques
Partage / Export
Résumé
The COVID-19 pandemic disrupted the continuing management of cardiovascular disease (CVD) risk factors in the population. Socioeconomic status (SES) is a major determinant of health. Whether the COVID-19 pandemic increased, the SES gap in CVD risk factors is unknown. To compare the management of CVD risk factors and the SES gap before and during the pandemic. Cross-sectional study conducted between 2018 and 2021 in Lausanne, Switzerland. Prevalence, awareness, treatment and control rates of hypertension, dyslipidaemia and diabetes were compared between the periods before (N=2416, 45.2% men, 65.3±9.8 years) and during (N=776, 44.5% men, 63.9±9.1 years) the COVID-19 pandemic. SES was defined by education and categorised as low (compulsory or apprenticeship), middle (high school) and high (university). After multivariable analysis, the prevalence of hypertension increased, and awareness decreased during the pandemic: OR and (95% CI) 1.26 (1.04 to 1.53) and 0.70 (0.53 to 0.94), respectively. For dyslipidaemia, prevalence decreased during the pandemic 0.82 (95% CI 0.69 to 0.98); awareness did not change. For diabetes, prevalence did not change but awareness increased 5.76 (95% CI 1.23 to 27.04). No differences were found before and during the pandemic regarding treatment and control for all CVD risk factors. Relative to high SES, a decrease in hypertension awareness among middle SES categories was observed during the pandemic (OR and 95% CI 1.11 (0.73 to 1.69) before and 0.45 (95% CI 0.23 to 0.85) during, p for interaction